AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer Ruchika Sharma1 April 2025 2:15 PM ISTImfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings.
Cetuximab outperforms durvalumab in treatment of head and neck cancers: Lancet Dr. Kamal Kant Kohli22 Nov 2024 8:30 PM ISTHead and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well...
Bristol Myers Squibb gets European Commission nod for Opdivo in combo with cisplatin, gemcitabine for urothelial carcinoma Ruchika Sharma30 May 2024 12:49 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with...
EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma Ruchika Sharma28 April 2024 11:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
Shilpa Medicare marketing partner unveils Pemrydi Rtu in US Ruchika Sharma20 April 2024 11:17 AM ISTPEMRYDI RTU is a novel ready-to-use injection which eliminates the need for refrigeration or reconstitution and dilution for administration to the...
USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
Shilpa Medicare gets Code J for Pemetrexed Injection Ruchika Sharma20 Jan 2024 12:30 PM ISTShilpa's - NDA Pemetrexed Injection, is a novel ready-to-use injection which eliminates the need for reconstitution and dilution before administration...
AstraZeneca Imfinzi plus chemotherapy approved in China for locally advanced or metastatic biliary tract cancer Ruchika Sharma19 Nov 2023 11:45 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Merck gets positive EMA Committee opinion for Keytruda plus Gemcitabine, Cisplatin for Biliary Tract Cancer Ruchika Sharma14 Nov 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the European Medicines Agency's Committee for Medicinal...
Merck bags USFDA nod for Keytruda plus gemcitabine, cisplatin to treat Biliary Tract Cancer Ruchika Sharma2 Nov 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
New Hope for Head and Neck Cancer Patients Ineligible for Cisplatin Dr Vijay Patil4 May 2023 9:30 AM ISTHead and neck squamous cell carcinoma (LAHNSCC) is a type of cancer that affects the head and neck area. It is often treated with radiotherapy, either...
Venus Remedies bags UK MHRA marketing nod for chemotherapy drug Cisplatin Ruchika Sharma27 April 2023 12:29 PM ISTChandigarh: Venus Remedies Ltd, a provider of cancer drugs worldwide, has secured marketing authorisation from the UK for Cisplatin, a...
